Director at United States Antimony (UAMY) awarded RSUs and options

Rhea-AI Filing Summary

United States Antimony Corp. granted equity awards to director John M. Keane as part of its Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he received time-based restricted stock units representing 7,464 shares of common stock, vesting in three equal installments of 2,488 shares on January 15, 2027, January 18, 2028, and January 16, 2029, subject to continued service. He was also granted a time-based stock option for 4,597 shares at an exercise price of $8.29 per share, vesting in three installments of 1,533 shares on the same dates, also conditioned on continued service as a director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEANE JOHN M

(Last) (First) (Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0.00	01/15/2026		A		7,464(1)		(1)	(1)	Common Stock	7,464	(1)	0(1)	D
Stock Option(2)	$8.29	01/15/2026		A		4,597(2)		(2)	(2)	Common Stock	4,597	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 2,488 shares of the 7,464 total number of shares of the RSU award will vest on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 1,533 shares of the 4,597 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

	/s/ John M Keane	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UAMY director John M. Keane report?

Director John M. Keane reported receiving equity compensation on January 15, 2026, consisting of time-based vesting restricted stock units and a stock option under United States Antimony Corp.'s Amended & Restated 2023 Equity Incentive Plan.

How many UAMY restricted stock units were granted to John M. Keane?

He was granted RSUs representing 7,464 shares of UAMY common stock. These vest in three equal installments of 2,488 shares on January 15, 2027, January 18, 2028, and January 16, 2029, subject to his continued service.

What stock options did UAMY grant to director John M. Keane?

He received a time-based vesting stock option covering 4,597 shares of UAMY common stock at an exercise price of $8.29 per share. The option vests as to 1,533 shares on each of January 15, 2027, January 18, 2028, and January 16, 2029, if he continues to serve through each date.

Is the UAMY Form 4 transaction a purchase or a grant?

The Form 4 reflects equity grants to a director, not open-market purchases or sales. The RSU and stock option awards were granted on January 15, 2026 as part of director compensation.

What role does John M. Keane hold at United States Antimony Corp. (UAMY)?

The filing identifies John M. Keane as a director of United States Antimony Corp. and indicates the Form 4 is filed by one reporting person.

What conditions apply to the vesting of UAMY equity awards granted to the director?

Both the RSU and stock option awards vest in three annual tranches and are subject to the reporting persons continued service with the company through each applicable vesting date.